Effects of sex and age on serum 1,5-anhydroglucitol in nondiabetic subjects

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 5, 2012, Pages 288-295

  Ouchi, M ^a   Oba, K ^a   Yamashita, H ^a   Okazaki, M ^a   Tsunoda, M ^a   Ohara, M ^a   Sekimizu, K ^a   Watanabe, K ^a   Suzuki, T ^a   Nakano, H ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

1,5 anhydroglucitol; age; glucosuria; nondiabetics; renal threshold; sex

Indexed keywords

1,5 ANHYDROSORBITOL; ALBUMIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

1,5 ANHYDROSORBITOL BLOOD LEVEL; ADOLESCENT; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ALCOHOL BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG USE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSURIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CREATININE; DEOXYGLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEX FACTORS; YOUNG ADULT;

EID: 84862808484     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1304604     Document Type: Article

References (35)

1. The DECODE study group on behalf of the European Diabetes Epidemiology Group Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet: 1999; 354 617 621
2. Ceriello A, Hanefeld M, Leiter L et al. for the International Prandial Glucose Regulation (PGR) Study group: Postprandial glucose regulation and diabetic complications. Arch Intern Med: 2004; 164 2090 2095
3. Tominaga M, Igarashi K, Eguchi H et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care: 1999; 22 920 924 (Pubitemid 29241045)
4. Watanabe K, Oba K, Suzuki T et al. Oral glucose loading attenuates endothelial function in normal individual. Eur J Clin Invest: 2011; 41 465 473
5. Weyer C, Bogardus C, Mott D M et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest: 1999; 104 787 794 (Pubitemid 29536364)
6. Gerich J E. Pathogenesis and treatment of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM). Horm Metab Res: 1996; 28 404 412 (Pubitemid 26343729)
7. Stickle D, Turk J. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol: 1997; 273 E821 E830
8. Yamanouchi T, Ogata N, Tagaya T et al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet: 1996; 347 1514 1518 (Pubitemid 26162642)
9. Yamanouchi T, Akanuma Y. Serum 1,5-anhydroglucitol (1,5-AG): new clinical marker for glycemic control. Diabetes Res Clin Pract: 1994; 24 S261 S268
10. Yoshioka K, Azukari K, Yoshida T et al. Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of -glucosidase inhibitor. Diabetes Care: 1997; 20 462 (Pubitemid 27098243)
11. Matsumoto K, Yano M, Miyake S et al. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Diabetes Care: 1998; 21 256 260 (Pubitemid 28079434)
12. Yamanouchi T, Akanuma H, Nakamura T et al. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients. Diabetologia: 1988; 31 41 45 (Pubitemid 18077571)
13. Funasako M, Taniji M, Fujimoto K et al. Effect of aging on plasma 1,5-anhydroglucitol levels in humans and rats. Diabetes Res Clin Pract: 1994; 25 35 41 (Pubitemid 24288044)
14. Tsukui S, Fukumura Y, Kobayashi I. Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with family history of NIDDM. Diabetes Care: 1996; 19 940 944 (Pubitemid 26301228)
15. Watanabe M, Kokubo Y, Higashiyama A et al. Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study. Atherosclerosis: 2011; 216 477 483
16. Fukumura Y, Tajima S, Oshitani S et al. Fully enzymatic method for detecting 1,5-anhydro-D-glucitol in serum. Clin Chem: 1994; 40 2013 2016 (Pubitemid 24346165)
17. Committee on Diabetes Mellitus Indices, Japan Society of Clinical Chemistry Japanese guideline for reporting HbA1c results reported in IFCC units and JDS units. Rinsho Kagaku: 2008; 37 393 409 (In Japanese)
18. Meguro S, Tomita M, Katsuki T et al. Plasma 25-hydroxyvitamin D is independently associated with hemoglobin concentration in male subjects with type 2 diabetes mellitus. Int J Endocrinol: 2011; (International Journal of Endocrinology Advance Access published on Jun 6, 2011 10.1155/2011/362981)
19. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc: 2010; 53 450 467
20. Matsuo S, Imai E, Horio M et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis: 2009; 53 982 992
21. Ohta M, Babazono T, Uchigata Y et al. Comparison of the prevalence of chronic kidney disease in Japanese patients with type 1 and type 2 diabetes. Diabet Med: 2010; 27 1017 1023
22. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care: 2003; 26 881 885 (Pubitemid 36929359)
23. Davidson M B. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism: 1979; 28 688 705 (Pubitemid 9187453)
24. Servo C, Palo J, Pitkänen E. Polyols in the cerebrospinal fluid and plasma of neurological, diabetic and uraemic patients. Acta Neurol Scand: 1977; 56 111 116 (Pubitemid 8147679)
25. Emoto M, Tabata T, Inoue T et al. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron: 1992; 61 181 186
26. Yamanouchi T, Tachibana Y, Akanuma H et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol: 1992; 263 E268 E273
27. Anonymous Daily fat and total food energy intakes. Third National Health and Nutrition Examination Survey. phase 1. 1988-1991. MMWR Morb Mortal Wkly Rep: 1994; 43 116 125
28. National Institute of Health and Nutrition, Japan Outline for the Results of the National Health and Nutrition Survey Japan. 2007; Available from http://www.nih.go.jp/eiken/english/research/pdf/nhns2007.pdf
29. th eds. On the nature and treatment of diabetes. Amsterdam Excerpta Medica Foundation: 1965; 601 611
30. Butterfield WJ H, Keen H, Whichelow M J. Renal glucose threshold variations with age. Br Med J: 1967; 4 505 507
31. Sandhu S, Wiebe N, Fried L F et al. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol: 2006; 17 2006 2016 (Pubitemid 44036185)
32. Sattar N, Preiss D, Murray H et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet: 2010; 375 735 742
33. Koga M, Murai J, Saito H et al. Close relationship between serum concentrations of 1,5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system. Clin Chim Acta: 2009; 410 70 73
34. Gotoh M, Li C, Yatoh M et al. Serum uric acid concentrations in type 2 diabetes: its significant relationship to serum 1,5-anhydroglucitol concentrations. Endocr Regul: 2005; 39 119 125 (Pubitemid 44788383)
35. Rafey M A, Lipkowitz M S, Leal-Pinto E et al. Uric acid transport. Curr Opin Nephrol Hypertens: 2003; 12 511 516 (Pubitemid 37083111)